Mark Cuban’s Cost-Plus pricing isn’t just a new way to buy medicine—it’s a direct hit on the business model pharma built around patents.
For years, the industry’s “patent playbook” has been simple: protect the molecule, defend the exclusivity, and mone…

Should you file a provisional patent for your drug invention? The honest answer.
In biotech and pharma, the question sounds simple: Should I file a provisional patent? But the real decision is rarely about paperwork. It’s about leverage—timing, risk, a…

The patent cliff isn’t a cliff. It’s a countdown.
If you’re waiting until the last year of a drug’s exclusivity to think about supply, you’re already late.
In pharma, the “patent cliff” narrative is familiar: blockbuster revenues taper, generics and …

The 180-Day FDA Exclusivity Race Isn’t a Sprint—It’s a Strategy War. Here’s the Playbook.
If you’re in generics, biosimilars, or specialty pharma, you already know the headline: the first applicant to win the 180-day FDA exclusivity can capture outsize…

The PBM Endgame: What Mark Cuban Got Right—and Why Pharma Still Isn’t Listening
The pharmacy benefit manager (PBM) debate has become a permanent fixture in healthcare headlines—yet the industry keeps arguing past the point.
Here’s the uncomfortable tru…

What long-term joint problems have been reported with Lipitor (atorvastatin)? Long-term joint side effects from Lipitor… https://www.Drugchatter.com/chat/47878/what-are-lipitor’s-long-term-joint-effects/

What long-term joint problems have been reported with Lipitor (atorvastatin)? Long-term joint side effects from Lipitor… https://www.Drugchatter.com/chat/47878/what-are-lipitor’s-long-term-joint-effects/

What long-term joint problems have been reported with Lipitor (atorvastatin)? Long-term joint side effects from Lipitor… https://www.Drugchatter.com/chat/47878/what-are-lipitor’s-long-term-joint-effects/

What long-term joint problems have been reported with Lipitor (atorvastatin)? Long-term joint side effects from Lipitor… https://www.Drugchatter.com/chat/47878/what-are-lipitor’s-long-term-joint-effects/